Kenneth Galbraith
CIK 1567045 · Chair & CEO · last filed 2026-01-12
Kenneth Galbraith is a Chair & CEO who has filed 20 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for ZYME, was dated Jan 12, 2026. Across all open-market trades the lifetime net is −$4.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $11.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$11.04M
2
20
-$4.26M
Holdings By Company
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-12 | ZYME | Mixed | +33,576 | -$689.8K | EDGAR |
| 2026-01-05 | ZYME | Mixed | +59,991 | -$1.36M | EDGAR |
| 2025-12-22 | ZYME | Mixed | +52,472 | -$1.28M | EDGAR |
| 2025-01-10 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2025-01-06 | ZYME | Mixed | +57,041 | -$855.0K | EDGAR |
| 2024-01-08 | ZYME | Mixed | +23,762 | -$257.8K | EDGAR |
| 2023-01-06 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2022-12-23 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2022-01-18 | ZYME | Grant (A) | — | $0 | EDGAR |
| 2021-05-17 | MGNX | Grant (A) | — | $0 | EDGAR |